Medicinal Chemistry and Pharmacokinetics_Chem22Module description #20818 / Version 2
- 6 CP
- Oral exam
- Graded
- Winter and summer semester
- German
| Module / Version | #20818 / #2 |
|---|---|
| Validity | Since Winter semester 2023/24 |
| Available language(s) | English, German |
| Credit points | 6 |
| Person responsible for the module | Süßmuth, Roderich |
| Grading | Graded |
| Exam format | Oral exam |
| Language(s) of instruction | German |
Affiliation
| Faculty | Fakultät II |
|---|---|
| Institute | Institut für Chemie |
| Academic chair | Not specified |
Contact
| Office | C 5 |
|---|---|
| Contact person | Winter, Kati |
| E-mail address | winter@chem.tu-berlin.de |
| Website | Not specified |
Learning outcomes
Participants will be able to explain modern methods of drug discovery, discuss their advantages and disadvantages, and evaluate them. They are familiar with the phases of the drug discovery process, the structures of important active compounds, their mechanisms of action, as well as basic terms, concepts, and mechanisms of pharmacodynamics and computer-aided drug discovery. In addition, participants will expand their knowledge using selected case studies from drug development (e.g., synthesis strategies, SAR, biological test systems). Participants are familiar with the fundamental terms and concepts of research in the field of pharmacology, with a focus on drug, metabolism, and pharmacokinetics (DMPK). They understand the relationships between the physical and chemical properties of drug structures and the resulting profiles during interaction with the organism. They can describe the biochemical fundamentals of drug release, drug transport, metabolism, Phase I and Phase II reactions, the structure and mechanisms of transporters, and excretion. In addition, participants will gain knowledge regarding the optimization of active ingredient molecular structures to more easily overcome physiological barriers. Furthermore, participants can explain the underlying selection and optimization criteria for active ingredients and apply them to unknown compounds. This applies equally to the application of analytical and biochemical methods associated with the aforementioned techniques.
Content
Development of medicinal chemistry, lead compound screening, natural products, principles of combinatorial chemistry, rules of structure design (homologization concept, isosteric concept, ring transformations, influence of chirality, twin drugs, surrogate structures), SAR and screening criteria (Lipinski’s rules, rule of five, rule of four, rule of three, ...), Drug Targets and Molecular Mechanisms, Ligand Properties (Efficacy & Potency, Agonist, Antagonist, Partial Agonist, Inverse Agonist, Modulator, Surmountable/Insurmountable, Kd, Ki, IC50, etc.), Enzymes as Targets, Receptors: ion channels/tyrosine-serine-threonine kinases/G-protein-coupled receptors/neural signal transduction (structure, function, mechanism of action), Definitions of various inhibitors, theory of receptor binding (Clark, Langley, Black-Leff, Schild plot), biologics (definition, production, insulin, GLP-1 agonists, EPO, therapeutic antibodies, antibody-toxin conjugates, advantages over small molecules), biosimilars, contributions of computational chemistry to drug design, case studies (examples from drug discovery). /// Pharmacokinetic barriers in drug delivery, sample preparation and analysis (HPLC-ESI mass spectrometry), ADME model, bioavailability, AUC, ADME assays (PAMPA, CaCo II, MetStab, etc.), solubility and permeability (pKa, logP, TSPA), membrane transport (active, passive, tight junctions), peptide formulation, tight-junction openers, first-pass effect, volume of distribution, enterohepatic circulation, prodrugs, anteiso drugs, organ structure (liver, kidney, membranes), Phase I and Phase II metabolism (enzymes, cofactors, degradation mechanisms, NIH effect, epoxidation, dealkylation, deamination), plasma stability and plasma protein binding, induction and inhibition of CYPs, transporters (SLIC, ABC/efflux transporters), toxicology
Module components
Compulsory area
The following courses are mandatory for this module:
| Courses | Type | Number | Frequency | Language | Hours per week | Course catalog |
|---|---|---|---|---|---|---|
| Medizinalchemie I | Integrated course | Winter semester | [de] | 2 | WS 2026/27 (1) ISIS | |
| Medizinalchemie II | Integrated course | Summer semester | [de] | 2 | ISIS |
Courses in the course catalog
Courses created from the teaching units of this module.
Winter semester 2026/27 (1)
Medizinalchemie I (Integrated course) 1
- Medizinalchemie I (Integrierte Veranstaltung) Termingruppe 1
Workload and credit points
Medizinalchemie I (Integrated course)
| Workload description | Multiplier | Hours | Total |
|---|---|---|---|
| Attendance | 15 | 2 h | 30 h |
| Pre/post processing | 15 | 4 h | 60 h |
| 90 h | |||
Medizinalchemie II (Integrated course)
| Workload description | Multiplier | Hours | Total |
|---|---|---|---|
| Attendance | 15 | 2 h | 30 h |
| Pre/post processing | 15 | 4 h | 60 h |
| 90 h | |||
The workload of the module adds up to 180 hours. The module therefore comprises 6 credit points.
Description of teaching and learning methods
Integrated course: Teaching of the above-mentioned course content through lectures by the instructor or external speakers, and in-depth exploration of the material through its application to problem-solving scenarios as well as short presentations by students.
Requirements for participation and examination
Desirable prerequisites for participation in the courses:
Bachelor of Science with a specialization in Biological Chemistry
Module “Biological Chemistry III”
Module “Biological Chemistry III”
Mandatory requirements for the module examination registration:
The examination requirements could not be retrieved.
Completion of the module
| Grading | Graded |
|---|---|
| Exam format | Oral exam |
| Language | German |
Duration of the module
The following number of semesters is estimated for taking and completing the module: 2 semester(s).
This module can be started in the following semesters: Winter and summer semester.
Maximum number of participants
This module is not limited to a number of students.
Registration procedures
Registration for the module exam takes place via the central online exam administration system.
Recommended reading, lecture notes
Lecture notes
unavailable
Electronic lecture notes
unavailable
Recommended literature
- Camille Georges Wermuth, The Practice of Medicinal Chemistry, 3. Auflage, Academic Press, Oxford, 2008.
- Gerhard Klebe, Wirkstoffdesign, 2. Auflage, Springer Spektrum, Heidelberg, 2009.
- Richard B. Silverman, The Organic Chemistry of Drug Design and Drug Action, 2. Auflage, Elsevier, London, 2004.
- Edward H. Kerns, and Li Di, Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization, Academic Press 2008.
Assigned programs
This module version is used in the following programs:
| Program / program version | Semester(s) | Curriculum component |
|---|---|---|
| Biological Chemistry StuPO 2024 | WS 2024/25 | Wahlpflichtbereich › Biologische Chemie / Organische Chemie › Wahlpflichtbereich Biologische Chemie / Organische Chemie |
| SS 2025 | Wahlpflichtbereich › Biologische Chemie / Organische Chemie › Wahlpflichtbereich Biologische Chemie / Organische Chemie | |
| WS 2025/26 | Wahlpflichtbereich › Biologische Chemie / Organische Chemie › Wahlpflichtbereich Biologische Chemie / Organische Chemie | |
| SS 2026 | Wahlpflichtbereich › Biologische Chemie / Organische Chemie › Wahlpflichtbereich Biologische Chemie / Organische Chemie | |
| WS 2026/27 | Wahlpflichtbereich › Biologische Chemie / Organische Chemie › Wahlpflichtbereich Biologische Chemie / Organische Chemie | |
| Chemistry StuPO 2022 | WS 2023/24 | Wahlpflichtbereich › Vertiefung Synthese und Katalyse |
| SS 2024 | Wahlpflichtbereich › Vertiefung Synthese und Katalyse | |
| WS 2024/25 | Wahlpflichtbereich › Vertiefung Synthese und Katalyse | |
| SS 2025 | Wahlpflichtbereich › Vertiefung Synthese und Katalyse | |
| WS 2025/26 | Wahlpflichtbereich › Vertiefung Synthese und Katalyse | |
| SS 2026 | Wahlpflichtbereich › Vertiefung Synthese und Katalyse | |
| WS 2026/27 | Wahlpflichtbereich › Vertiefung Biophysikalische und Biologische Chemie |
Target audience: Students in the M.Sc. Chemistry program (required elective areas: “Biophysical and Biological Chemistry,” “Synthesis and Catalysis”), the M.Sc. Biological Chemistry program (required elective area), as well as auditors from all disciplines (free elective area)
Miscellaneous
[Contains machine generated translations 2026-07-07 11:17, only the German version is legally binding]
Credit for the short presentation can be earned as part of the Medicinal Chemistry I or Medicinal Chemistry II course.
Credit for the short presentation can be earned as part of the Medicinal Chemistry I or Medicinal Chemistry II course.